In July, the Cannabis Employment Protections Amendment Act of 2022 was signed by the mayor of Washington, D.C., prohibiting most employers from taking adverse action for off-duty cannabis use. The bill, which also amends the District of Columbia’s medical cannabis law to require most employers to treat a qualifying patient’s use of medical cannabis for a disability in the same manner as it would treat the legal use of other controlled substances prescribed by or taken under the supervision of a licensed health care professional, must go through a congressional review period before becoming law.